Hemoglobin Targets and Blood Transfusions in Hemodialysis Patients without Symptomatic Cardiac Disease Receiving Erythropoietin Therapy-Reference-Cited by-同舟云学术

Hemoglobin Targets and Blood Transfusions in Hemodialysis Patients without Symptomatic Cardiac Disease Receiving Erythropoietin Therapy

Published:2008-10-15 Issue:6 Volume:3 Page:1669-1675
ISSN:1555-9041
Container-title:Clinical Journal of the American Society of Nephrology
language:en
Short-container-title:CJASN

Author:

Foley Robert N.,Curtis Bryan M.,Parfrey Patrick S.

Publisher

American Society of Nephrology (ASN)

Subject

Transplantation,Nephrology,Critical Care and Intensive Care Medicine,Epidemiology

Reference19 articles.

1. Anemia in Hemodialysis Patients

2. Erythropoietin Therapy

3. Follow Up to the January 3, 2008 Communication About an Ongoing Safety Review Erythropoiesis-Stimulating Agents (ESAs) Epoetin alfa (marketed as Procrit, Epogen) Darbepoetin alfa (marketed as Aranesp). Available at: http://www.fda.gov/cder/drug/infopage/RHE. Accessed March2008 .

4. Transfusion Medicine — Blood Transfusion

5. Zhou YC, Cecka JM: Sensitization in renal transplantation. Clin Transplant 313– 323,1991

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blood Hemoglobin Concentrations and the Incidence of Lower Extremity Peripheral Arterial Disease in Patients Undergoing Hemodialysis: 10‐Year Outcomes of the Q‐Cohort Study;Journal of the American Heart Association;2024-08-06

2. Interventions for fatigue in people with kidney failure requiring dialysis;Cochrane Database of Systematic Reviews;2023-08-31

3. Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis;Cochrane Database of Systematic Reviews;2023-02-13

4. Anemia in Dialysis Patients;Complications in Dialysis;2023

5. Treatment of Anemia in Chronic Kidney Disease;Evidence‐Based Nephrology;2022-11-18